PASG Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Passage Bio Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerPASG

Market Cap18.8M

Cash RunwayRunway 6-12 months

Next Catalyst2030-11-01

Public Research Snapshot

Passage Bio Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for PBFT02 (Phase 1/2) using Gene Therapy.

Pipeline

Asset	Indication	Modality	Stage	Public Note
PBFT02	n/a	Gene Therapy	Phase 1/2	Public pipeline row
Cerebellar theta burst stimulation	Spinal Cord Injuries and Disorders (SCI/D)	n/a	Na	Public pipeline row
The Myelin Disorders Biorepository Project	n/a	n/a	n/a	Public pipeline row
NICOM (non-invasive cardiac output monitor)	Heart Diseases in Pregnancy \| Congenital Heart Disease in Pregnancy	n/a	n/a	Public pipeline row
Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients	GM1 Gangliosidosis	n/a	n/a	Public pipeline row
BC-006 + Meal	Digestive Health \| Gastrointestinal Health	n/a	Na	Public pipeline row

Catalyst Preview

Company	Ticker	Catalyst	Timing	Asset	Confidence
		Clinical Trial Completion	2030-11-01	Cerebellar theta burst stimulation	Low
		Clinical Trial Completion	2030-12-08	The Myelin Disorders Biorepository Project	Low

Cash Runway Preview

Estimated cash runway: Runway 6-12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT03616730	n/a	TERMINATED	100	2022-06-30
NCT05211440	Na	COMPLETED	30	2023-08-25
NCT04041102	n/a	COMPLETED	31	2024-05-01
NCT07423949	Na	NOT_YET_RECRUITING	24	2030-11-01
NCT03047369	n/a	RECRUITING	12000	2030-12-08

Scientific Context

literature_publication | Civilian post-traumatic epilepsy: Clinical and socioeconomic characteristics.
literature_publication | Developmental trajectory of individuals with Pelizaeus-Merzbacher Disease (PMD).
literature_publication | Alzheimer's Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults.
literature_publication | Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
literature_publication | Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.

Want the full PASG research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.